about
Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation.RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated CancerTreatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patientsFap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression.Restoring inflammatory balance as a potential preventive strategy for inflammation induced cancer.RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation.Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer.Focal and Local: Ectopic Lymphoid Structures and Aggregates of Myeloid and Other Immune Cells in Liver.SIRT6 Overexpression Improves Various Aspects of Mouse Healthspan.Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy.WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.Postnatal DNA demethylation and its role in tissue maturation.Vav1 mutations identified in human cancers give rise to different oncogenic phenotypesSmall Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical ModelsmicroRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress HepatocarcinogenesisVICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in miceAre we ready for targeted therapy combinations in HCC?Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2
P50
Q34709078-82C39C23-189F-4394-98A4-7312F6619E14Q36599713-99486E02-47BC-4707-A7A4-540C2D202951Q38374414-33CC4CB3-6629-4765-9181-140DA78EA9D8Q38752482-A2B65F6D-A1D4-4BD0-964C-581F6D1C0497Q38948066-1C7BA7FC-C13C-4F2D-A9EC-B48D64F32B26Q39767815-FD41E431-F237-4E00-8BDE-D5C00C9B2154Q40256058-BA5F00D8-09AA-468C-8BB3-E94698DC5443Q40449406-62BD6409-5F3E-49E2-9F3A-9392CB4BFCA3Q42505152-CDD12016-3DB4-4F7E-A6A6-952B8AF5A434Q50468454-00BB4855-E598-4AF9-8B99-16791980AD39Q50594777-1870D840-65C8-4ED4-A759-133A22297882Q50753598-CE3598F3-F2A1-4761-948B-FEA67C91076CQ51574303-59EFF34F-78D5-4533-A074-2DF8508D5265Q52642822-5A638241-EECE-4273-AD19-81F936FF5A21Q55003004-AD2A75CF-DF36-41D5-BF7B-91537F8FD4B2Q55259043-D6D8D1BC-B91C-4617-A4E7-2AA200F6C491Q57295717-9D42936E-570C-48E7-8FF0-C1B33FD81E72Q91145383-BE534E28-429C-42AE-93DA-D16867E5D28CQ91231335-FBA2963D-2411-42EC-A39D-DB45A53127CCQ91283847-D15F00DE-2103-4359-BFB0-E10223C9BB8FQ92502775-7EF39B54-4DB6-451B-A1D9-D0E0E4DC9363Q92635176-D21556D6-2A14-4879-B989-07E85CD9DAD1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
eli pikarsky
@ast
eli pikarsky
@en
eli pikarsky
@nl
type
label
eli pikarsky
@ast
eli pikarsky
@en
eli pikarsky
@nl
prefLabel
eli pikarsky
@ast
eli pikarsky
@en
eli pikarsky
@nl
P106
P31
P496
0000-0003-4186-7105